Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development. Pharmaceutical companies walk a tightrope in early drug development.

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...

Formulation development can involve several complex technical challenges, but an approach incorporating design of experiments can help address these difficulties. All pharmaceutical drug products are ...

Delve into the heart of vaccine development with our three-day virtual masterclass, guided by the esteemed Dr. Tudor Arvinte. This immersive course offers a unique blend of scientific rigor and ...

The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...

Yield ramp has historically been the fab's burden. The yield ramp cycle was cleanly partitioned into three phases: process development, pilot production and volume production (Fig. 1). 1. Industry has ...

SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full ...

InProcess-LSP is a relatively new, dynamic organization launched in 2014. The company combines the expertise and experience of three Process Analytical Technology (PAT) scientists and is based at the ...